LNF2007 not checked

Shandong New Time Pharmaceutical Co., LTD

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“LNF2007,9 dose groups:0.2μg/kg、1μg/kg、5μg/kg、20μg/kg、60μg/kg、120μg/kg、240μg/kg、360μg/kg、540μg/kg(0.2\~5μg/kg for "accelerated titration", and i3+3 ramp-up starting from 20μg/kg dose group),IV, infusion time 60min±10min, Q4W, until disease progression 、intolerable toxicity or other reasons to stop treatment, the longest administration to 2 years, whichever occurs first.”In the company’s words, NCT06752447 on ClinicalTrials.gov
Tested for
Advanced Solid Tumors (Phase 1)
Main trialPhase 1
“A non-randomized, open-ended, phase I dose-escalation and dose-expansion study was designed to evaluate the safety, tolerability, antitumor efficacy, PK and immunogenic characteristics of LNF2007 in patients with advanced solid tumors”In the company’s words, NCT06752447 on ClinicalTrials.gov

Other drugs for Advanced Solid Tumors (Phase 1)

All 86 drugs for Advanced Solid Tumors (Phase 1)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Not yet recruiting Dec 2026 A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow LNF2007

Following is part of Solo: you see every change to LNF2007 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in